Quantcast

Pine State News

Thursday, November 14, 2024

Maine: Biologics companies were the second most FDA inspected companies in Maine in Q1 2023

Webp ishuwpt6uyanzpnvvfpnzrwi0yoq

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

In the first quarter of 2023, four Biologics companies received four FDA inspections in Maine, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Maine, equalling 28.6% of all inspections in the first quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Maine During Q1 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products3----
Compliance: Devices1----
Food Composition, Standards, Labeling and Econ11--
Foodborne Biological Hazards63--
Human Cellular, Tissue, and Gene Therapies2----
Postmarket Assurance: Devices1----
Technical Assistance: Food and Cosmetics1----
Vaccines and Allergenic Products4----

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS